AMZN
Amazon.com, Inc.
AMZN has lower modeled downside risk, despite its lower overall score.
FIGS
FIGS, Inc.
FIGS has the edge over AMZN overall, supported by stronger fundamentals and stronger valuation.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
FIGS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
FIGS's revenue, profitability, cash flow and balance sheet are all currently healthy.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over FIGS in the historical PE scenario, which offers more potential upside but is not a forecast.
FIGS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 48x | $18.14 | -20% |
| Forward | 57x | $22.68 | — |
| Current | 60x | $22.68 | — |
| Fair | 86x | $32.55 | +43% |
| Expensive | 177x | $67.36 | +197% |
Historical ranges are pointers, not guarantees.
FIGS's PE is in its cheap range at 60x. If earnings grow as analysts expect, today's price would be 57x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
FIGS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
FIGS has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN's earnings per share have climbed steadily: $12.37 over the past year, up 75% from the year before, and higher year over year for 14 quarters in a row. Its recent earnings include one-off gains.
FIGS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.40 | +5.3% |
| Q3 2026 | $0.38 | +280% |
| Q2 2026 | $0.33 | +725% |
| Q1 2026 | $0.22 | +2100% |
| Q4 2025 | $0.19 | +850% |
| Q3 2025 | $0.10 | +43% |
| Q2 2025 | $0.04 | -64% |
| Q1 2025 | $0.01 | -92% |
| Q4 2024 | $0.02 | -83% |
FIGS's earnings per share have jumped to their highest in five years: $0.38 over the past year, up from $0.10 the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over FIGS on profitability, with a higher operating margin.
FIGS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $190.7M | +26% |
| Q2 2026 | $196.6M | +29% |
| Q1 2026 | $159.9M | +28% |
| Q4 2025 | $201.9M | +33% |
| Q3 2025 | $151.7M | +8.2% |
| Q2 2025 | $152.6M | +5.8% |
| Q1 2025 | $124.9M | +4.7% |
| Q4 2024 | $151.8M | +4.8% |
FIGS has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | +5.3 points |
| Q2 2026 | 18% | +11 points |
| Q1 2026 | 2.8% | +3 points |
| Q4 2025 | 9.3% | +3.5 points |
| Q3 2025 | 6.3% | +13 points |
| Q2 2025 | 6.5% | +5.4 points |
| Q1 2025 | -0.2% | -0.5 points |
| Q4 2024 | 5.9% | -4 points |
FIGS's operating margin was 12% last quarter, up 5.3 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
FIGS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $51.2M | +9538% |
| Q2 2026 | $44.3M | +$57.8M |
| Q1 2026 | -$5.6M | -171% |
| Q4 2025 | $58.1M | +115% |
| Q3 2025 | $531K | -97% |
| Q2 2025 | -$13.5M | -279% |
| Q1 2025 | $7.9M | -29% |
| Q4 2024 | $27.1M | +98% |
FIGS has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over FIGS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
FIGS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -1.9M shares |
| 1 year | +6.9% | +12.4M shares |
| 3 years | +6.5% | +11.8M shares |
| 5 years | +23% | +36.4M shares |
| Available history | +21% | +33.1M shares |
FIGS has 193M diluted shares, up 6.9% from a year ago, despite $47M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $13.8M |
| Q2 2026 | $24M |
| Q1 2026 | $8.8M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $2.7M |
| Q4 2024 | $38.2M |
FIGS spent $47M buying back its own shares over the past year, up 14% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
FIGS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.4x | Net Cash |
| Q4 2025 | -1.7x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -2.7x | Net Cash |
| Q1 2025 | -9.5x | Net Cash |
| Q4 2024 | -9.6x | Net Cash |
FIGS has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
FIGS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.3 | Overbought |
| Stochastic | 87.1 | Overbought |
FIGS's weekly RSI is 73 (overbought) and its Stochastic is 87 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over FIGS on valuation relative to its sector.
FIGS PE vs Consumer Cyclical Sector
| Metric | FIGS | Sector median | Relative |
|---|---|---|---|
| PE | 60x | 18x | 231% above |
| PE % | 32 | 54 | 22 pts below |
FIGS is trading at 60x earnings, a 231% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
FIGS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.2 | 24% above |
| 20 week MA | $14.8 | 53% above |
| 50 week MA | $13.6 | 67% above |
| 100 week MA | $9.82 | 131% above |
| 200 week MA | $8.09 | 180% above |
FIGS is in an uptrend: it's above all five of its weekly moving averages, and 180% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
FIGS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $34.2 | $26.4 | -23% |
| 2022 | $26.4 | $6.72 | -75% |
| 2023 | $6.72 | $6.95 | +3.4% |
| 2024 | $6.95 | $6.01 | -14% |
| 2025 | $6.01 | $11.8 | +97% |
| 2026 YTD | $11.8 | $22.7 | +92% |
FIGS has the edge over AMZN on returns for 2026, with the stronger performance.